Cargando…
Diversity of small molecule HIV‐1 latency reversing agents identified in low‐ and high‐throughput small molecule screens
The latency phenomenon produced by human immunodeficiency virus (HIV‐1) prevents viral clearance by current therapies, and consequently development of a cure for HIV‐1 disease represents a formidable challenge. Research over the past decade has resulted in identification of small molecules that are...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216841/ https://www.ncbi.nlm.nih.gov/pubmed/31608481 http://dx.doi.org/10.1002/med.21638 |